11.02
price up icon0.27%   0.03
after-market Dopo l'orario di chiusura: 11.02
loading

Keros Therapeutics Inc Azioni (KROS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
97.31%
0.38
14.12 18.17 211.19 3.042
Operating Expenses
0.03%
29.66
29.65 57.98 59.21 56.30
Benefits Costs and Expenses
11.07%
25.36
22.83 51.09 52.70 190.60
Costs And Expenses
11.07%
25.36
22.83 51.09 52.70 32.52
Operating Income/Loss
90.26%
-29.27
-15.38 -39.82 152.04 -53.25
Nonoperating Income/Loss
35.70%
4.295
6.68 6.899 6.454 7.528
Income/Loss From Continuing Operations Before Tax
186.94%
-24.98
-8.704 -32.92 158.49 -187.56
Income Tax Expense/Benefit
6.32%
-1.514
-1.424 -2.222 10.04 -
Income/Loss From Continuing Operations After Tax
222.27%
-23.46
-7.28 -30.70 148.45 -46.03
Net Income/Loss
222.27%
-23.46
-7.28 -30.70 148.45 -46.03
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
108.31%
-3.3776
40.62 40.61 40.56 0.9737
Diluted Average Shares
108.23%
-3.3433
40.62 40.61 41.02 0.9737
Basic Earnings Per Share
111.11%
-0.38
-0.18 -0.76 3.66 -1.12
Diluted Earnings Per Share
111.11%
-0.38
-0.18 -0.76 3.62 -1.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):